These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20170566)

  • 1. [Sepsis: new insights into its pathogenesis and treatment].
    Wiersinga WJ; van der Poll T
    Ned Tijdschr Geneeskd; 2010; 154():A1130. PubMed ID: 20170566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.
    Balk RA
    Dis Mon; 2004 Apr; 50(4):168-213. PubMed ID: 15133467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sepsis in the critically-ill patient].
    Christensen VB; Nielsen JS; Tønnesen EK
    Ugeskr Laeger; 2007 Feb; 169(8):703-5. PubMed ID: 17313921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the pathogenesis and therapy of sepsis and septic shock.
    Llewelyn M; Cohen J
    Curr Clin Top Infect Dis; 2001; 21():148-71. PubMed ID: 11572150
    [No Abstract]   [Full Text] [Related]  

  • 6. New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis.
    Huttunen R; Aittoniemi J
    J Infect; 2011 Dec; 63(6):407-19. PubMed ID: 21840338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sepsis: a roadmap for future research.
    Cohen J; Vincent JL; Adhikari NK; Machado FR; Angus DC; Calandra T; Jaton K; Giulieri S; Delaloye J; Opal S; Tracey K; van der Poll T; Pelfrene E
    Lancet Infect Dis; 2015 May; 15(5):581-614. PubMed ID: 25932591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neonatal sepsis caused by Streptococcus agalactiae. What should be done?].
    Montero Alonso R; Barbadillo Izquierdo F; Ansó Oliván S; Marrero Calvo M; Carpintero Martín I; Sastre Huerta E; Alonso Alvarez B
    An Esp Pediatr; 1998 Mar; 48(3):288-92. PubMed ID: 9608091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis.
    Opal SM
    Int J Med Microbiol; 2007 Sep; 297(5):365-77. PubMed ID: 17452016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative bacterial/fungal infections: a challenging problem in critically ill patients after abdominal surgery.
    Lichtenstern C; Schmidt J; Knaebel HP; Martin E; Büchler MW; Weigand MA
    Dig Surg; 2007; 24(1):1-11. PubMed ID: 17259712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host-pathogen interactions in sepsis.
    van der Poll T; Opal SM
    Lancet Infect Dis; 2008 Jan; 8(1):32-43. PubMed ID: 18063412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into severe sepsis in older patients: from epidemiology to evidence-based management.
    Girard TD; Opal SM; Ely EW
    Clin Infect Dis; 2005 Mar; 40(5):719-27. PubMed ID: 15714419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin replacement in patients with sepsis and septic shock.
    Giudici D; Baudo F; Palareti G; Ravizza A; Ridolfi L; D' Angelo A
    Haematologica; 1999 May; 84(5):452-60. PubMed ID: 10329925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
    Janković B; Pasić S; Marković M; Veljković D; Milicić M
    Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sepsis management -- antibiotic therapy].
    Welte T
    Dtsch Med Wochenschr; 2004 Nov; 129(48):2609-13. PubMed ID: 15558411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure.
    Eisele B; Lamy M
    Semin Thromb Hemost; 1998; 24(1):71-80. PubMed ID: 9515782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis and septic shock.
    Zanetti G; Baumgartner JD; Glauser MP
    Schweiz Med Wochenschr; 1997 Mar; 127(12):489-99. PubMed ID: 9106949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial.
    MacArthur RD; Miller M; Albertson T; Panacek E; Johnson D; Teoh L; Barchuk W
    Clin Infect Dis; 2004 Jan; 38(2):284-8. PubMed ID: 14699463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Principles of antibacterial therapy of sepsis].
    Igonin AA; Kukes VG
    Klin Med (Mosk); 2003; 81(6):61-5. PubMed ID: 12875196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.